Related Experiment Video
Updated: Jul 25, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Hepatobiliary disorders in inflammatory bowel disease.
Physicians managing inflammatory bowel disease (IBD) should monitor for liver and biliary disorders, using serum alkaline phosphatase as a key indicator. Colectomy decisions for IBD should prioritize colonic disease severity, not liver conditions.
Area of Science:
- Gastroenterology
- Hepatology
- Internal Medicine
Background:
- Inflammatory bowel disease (IBD) patients are at risk for hepatobiliary disorders.
- Early detection and management of liver dysfunction are crucial in IBD care.
- Serum alkaline phosphatase is a primary biochemical marker for hepatic dysfunction.
Purpose of the Study:
- To outline monitoring strategies for hepatobiliary disorders in IBD patients.
- To discuss the diagnostic approach for suspected liver involvement in IBD.
- To clarify management principles for IBD-associated hepatobiliary conditions and the role of colectomy.
Main Methods:
- Regular monitoring of serum alkaline phosphatase levels (six-monthly intervals).
- Clinical assessment for signs of hepatic dysfunction (e.g., jaundice, hepatomegaly).
- Further investigations including biliary tree imaging and liver biopsy when indicated.
Main Results:
- Persistent elevation of serum alkaline phosphatase or clinical symptoms necessitate further investigation.
- Most IBD-associated hepatobiliary disorders are histologic abnormalities with minor clinical significance.
- Conflicting evidence exists regarding colectomy's role in preventing or treating liver disease.
Conclusions:
- Hepatobiliary disorders require vigilant monitoring in IBD patients, particularly those with extensive colonic disease.
- Management should be individualized based on the specific hepatobiliary disorder.
- Colectomy indications in IBD should primarily be driven by the severity of colonic disease, not concurrent liver issues.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease IV: Clinical Manifestations

